Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide to Predict Clinical Course in Patients With Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 98, Issue 11, 2006, Pages 1504-1506

  Mutlu, Bulent ^a   Bayrak, Fatih ^b   Kahveci, Gokhan ^a   Degertekin, Muzaffer ^b   Eroglu, Elif ^a   Basaran, Yelda ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DEATH; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33751170435     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.06.053     Document Type: Article

References (13)

1. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., Ohnishi M., Sawaki M., Fujii M., Horie H., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
2. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
3. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., Buttimore R.C., Lainchbury J.G., Elliott J.M., Ikram M., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
4. Omland T., Aakvaag A., Bonarjee V.V., Caidahl K., Lie R.T., Nilsen D.W., Sundsfjord J.A., and Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
5. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
6. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
7. Olsen M.H., Wachtell K., Tuxen C., Fossum E., Bang L.E., Hall C., Ibsen H., Rokkedal J., Devereux R.B., and Hildebrandt P. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertension 22 (2004) 1597-1604
8. Lim P., Monin J.L., Monchi M., Garot J., Pasquet A., Hittinger L., Vanoverschelde J.L., Carayon A., and Gueret P. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 25 (2004) 2048-2053
9. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
10. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
11. Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., and Maron B.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
12. Cheng V., Kazanegra R., Garcia A., Krishnaswamy P., Gardetto N., Clopton P., and Maisel A. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37 (2001) 386-391
13. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., Bouvier E., and Solal A.C. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641